A new era of menopause treatment looks to be on the horizon.
The drug is now poised to become the first non-hormonal medication of its kind approved in the world.
Hot flashes and night sweatsare common symptoms of menopause, affecting around 80% of women in their lifetime.
© Douglas Sacha via Getty
But in the early 2010s, scientists finally started to unravel some of the mechanisms underlying hot flashes.
Later studies found that blocking the activity of some receptors on these cells could safely reduce hot flashes.
The results follow equally promising findings from the companys other Phase III trial of elinzanetant,announcedearlier this March.
As important as the arrival of these drugs is, though, there is the thorny issue of cost.
News from the future, delivered to your present.
